Performance of Non-Invasive Monitors During ANH

Hemodilution Clinical Trial

Official title:
The Evaluation of Minimally Invasive Hemodynamic Monitors for the Assessment of Volume Responsiveness to Various Standard Replacement Fluids During Acute Normovolemic Hemodilution

Status Withdrawn

Clinical Trial Summary

The aim of this study is to assess the responsiveness of the standard minimally invasive hemodynamic monitors used in the operating room to known changes in the intravascular volume status that occur during blood removal and volume replacement with three different standard fluids used during ANH.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02179827
Study type	Observational
Source	University of California, Davis
Contact
Status	Withdrawn
Phase
Start date	November 2022
Completion date	November 2024

View Details

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04870073` - Retrograde Autologous Priming and Mannitol for Reducing Hemodilution in Cardiac Surgery	Phase 3
Terminated	`NCT00637468` - EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye	Phase 3
Recruiting	`NCT05606536` - The Impact of Intra-operative Fluid Infusion Rate on Microcirculation	N/A
Completed	`NCT02318355` - Proving Hemodilution in a Human Model for Class I Hemorrhage	N/A
Not yet recruiting	`NCT06399536` - Individualized ANH for Non-cardiac Surgery	N/A
Completed	`NCT01382134` - Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction	N/A